메뉴 건너뛰기




Volumn 13, Issue 10, 2014, Pages 2352-2360

Systemic delivery of a miR34a mimic as a potential therapeutic for liver cancer

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 34A; PROTEIN P53; BIOMIMETIC MATERIAL; MESSENGER RNA; MICRORNA; MIRN34 MICRORNA, HUMAN;

EID: 84924981388     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-14-0209     Document Type: Article
Times cited : (144)

References (44)
  • 1
    • 79960530841 scopus 로고    scopus 로고
    • In vivo delivery of RNAi with lipid-based nanoparticles
    • Huang L, Liu Y. In vivo delivery of RNAi with lipid-based nanoparticles. Annu Rev Biomed Eng 2011;13:507-30.
    • (2011) Annu Rev Biomed Eng , vol.13 , pp. 507-530
    • Huang, L.1    Liu, Y.2
  • 2
    • 43549112555 scopus 로고    scopus 로고
    • Novel therapies for cancer: Why dirty might be better
    • Fojo T. Novel therapies for cancer: why dirty might be better. Oncologist 2008;13:277-83.
    • (2008) Oncologist , vol.13 , pp. 277-283
    • Fojo, T.1
  • 3
    • 77956901498 scopus 로고    scopus 로고
    • The promise of microRNA replacement therapy
    • Bader AG, Brown D, Winkler M. The promise of microRNA replacement therapy. Cancer Res 2010;70:7027-30.
    • (2010) Cancer Res , vol.70 , pp. 7027-7030
    • Bader, A.G.1    Brown, D.2    Winkler, M.3
  • 4
    • 58549114916 scopus 로고    scopus 로고
    • miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells
    • Li N, Fu H, Tie Y, Hu Z, Kong W, Wu Y, et al. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Lett 2009;275:44-53.
    • (2009) Cancer Lett , vol.275 , pp. 44-53
    • Li, N.1    Fu, H.2    Tie, Y.3    Hu, Z.4    Kong, W.5    Wu, Y.6
  • 5
    • 77953920780 scopus 로고    scopus 로고
    • MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells
    • Pang R, Leung C, Ye T, Liu W, Chiu P, Lam K, et al. MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells. Carcinogenesis 2010;31:1037-44.
    • (2010) Carcinogenesis , vol.31 , pp. 1037-1044
    • Pang, R.1    Leung, C.2    Ye, T.3    Liu, W.4    Chiu, P.5    Lam, K.6
  • 6
    • 34250868124 scopus 로고    scopus 로고
    • Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: MiR-34a is a p53 target that induces apoptosis and G1-arrest
    • Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, Menssen A, et al. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 2007;6:1586-93.
    • (2007) Cell Cycle , vol.6 , pp. 1586-1593
    • Tarasov, V.1    Jung, P.2    Verdoodt, B.3    Lodygin, D.4    Epanchintsev, A.5    Menssen, A.6
  • 7
    • 34848868157 scopus 로고    scopus 로고
    • Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway inhuman colon cancer cells
    • Tazawa H, Tsuchiya N, Izumiya M, Nakagama H. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway inhuman colon cancer cells. Proc Natl Acad Sci U S A 2007;104:15472-7.
    • (2007) Proc Natl Acad Sci U S A , vol.104 , pp. 15472-15477
    • Tazawa, H.1    Tsuchiya, N.2    Izumiya, M.3    Nakagama, H.4
  • 8
    • 79751473114 scopus 로고    scopus 로고
    • The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
    • Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H, et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med 2011;17:211-5.
    • (2011) Nat Med , vol.17 , pp. 211-215
    • Liu, C.1    Kelnar, K.2    Liu, B.3    Chen, X.4    Calhoun-Davis, T.5    Li, H.6
  • 9
    • 80052316514 scopus 로고    scopus 로고
    • Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells
    • Nalls D, Tang SN, Rodova M, Srivastava RK, Shankar S. Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells. PLoS ONE 2011;6:e24099.
    • (2011) PLoS ONE , vol.6 , pp. e24099
    • Nalls, D.1    Tang, S.N.2    Rodova, M.3    Srivastava, R.K.4    Shankar, S.5
  • 10
    • 53949090314 scopus 로고    scopus 로고
    • Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres
    • Ji Q, Xinbao Hao X, Meng Y, Zhang M, DeSano J, Fan D, et al. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer 2008;8:266.
    • (2008) BMC Cancer , vol.8 , pp. 266
    • Ji, Q.1    Xinbao Hao, X.2    Meng, Y.3    Zhang, M.4    DeSano, J.5    Fan, D.6
  • 11
    • 84869083907 scopus 로고    scopus 로고
    • Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo
    • Craig VJ, Tzankov A, Flori M, Schmid CA, Bader AG, Müller A. Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo. Leukemia 2012;26:2421-4.
    • (2012) Leukemia , vol.26 , pp. 2421-2424
    • Craig, V.J.1    Tzankov, A.2    Flori, M.3    Schmid, C.A.4    Bader, A.G.5    Müller, A.6
  • 12
    • 77955022405 scopus 로고    scopus 로고
    • Development of a lung cancer therapeutic based on the tumor suppressor MicroRNA-34
    • Wiggins JF, Ruffino L, Kelnar K, Omotola M, Patrawala L, Brown D, et al. Development of a lung cancer therapeutic based on the tumor suppressor MicroRNA-34. Cancer Res 2010;70:5923-30.
    • (2010) Cancer Res , vol.70 , pp. 5923-5930
    • Wiggins, J.F.1    Ruffino, L.2    Kelnar, K.3    Omotola, M.4    Patrawala, L.5    Brown, D.6
  • 13
    • 84896049687 scopus 로고    scopus 로고
    • Aphase 1 study of the BCL2-targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors
    • Tolcher AW, Rodrigueza WV, Rasco DW, Patnaik A, Papadopoulos KP, Amaya A, et al. Aphase 1 study of the BCL2-targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors. Cancer Chemother Pharmacol 2014;73:363-71.
    • (2014) Cancer Chemother Pharmacol , vol.73 , pp. 363-371
    • Tolcher, A.W.1    Rodrigueza, W.V.2    Rasco, D.W.3    Patnaik, A.4    Papadopoulos, K.P.5    Amaya, A.6
  • 14
    • 65249154820 scopus 로고    scopus 로고
    • Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis
    • Andreakos E, Rauchhaus U, Stavropoulos A, Endert G, Wendisch V, Benahmed AS, et al. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis. Arthritis Rheum 2009;60:994-1005.
    • (2009) Arthritis Rheum , vol.60 , pp. 994-1005
    • Andreakos, E.1    Rauchhaus, U.2    Stavropoulos, A.3    Endert, G.4    Wendisch, V.5    Benahmed, A.S.6
  • 16
    • 77956627711 scopus 로고    scopus 로고
    • The role of signaling pathways in the development and treatment of hepatocellular carcinoma
    • Whittaker S, Marais R, Zhu AX. The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene 2010;29:4989-5005.
    • (2010) Oncogene , vol.29 , pp. 4989-5005
    • Whittaker, S.1    Marais, R.2    Zhu, A.X.3
  • 17
    • 84866259297 scopus 로고    scopus 로고
    • Molecular mechanisms of liver injury and hepatocarcinogenesis: Focusing on the role of stress-activated MAPK
    • 172894
    • Nakagawa H, Maeda S. Molecular mechanisms of liver injury and hepatocarcinogenesis: focusing on the role of stress-activated MAPK. Patholog Res Int 2012;172894:1-14.
    • (2012) Patholog Res Int , pp. 1-14
    • Nakagawa, H.1    Maeda, S.2
  • 18
    • 84870518210 scopus 로고    scopus 로고
    • Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development
    • Wu K, Ding J, Chen C, Sun W, Ning BF, Wen W, et al. Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development. Hepatology 2012;56:2255-67.
    • (2012) Hepatology , vol.56 , pp. 2255-2267
    • Wu, K.1    Ding, J.2    Chen, C.3    Sun, W.4    Ning, B.F.5    Wen, W.6
  • 20
    • 80054978000 scopus 로고    scopus 로고
    • Development of a human whole blood assay for prediction of cytokine release similar to anti-CD28 superagonists using multiplex cytokine and hierarchical cluster analysis
    • Walker MR, Makropoulos DA, Achuthanandam R, Vaan Arsdell S, Bugelski P. Development of a human whole blood assay for prediction of cytokine release similar to anti-CD28 superagonists using multiplex cytokine and hierarchical cluster analysis. Int Immunopharmacol 2011;11:1697-705.
    • (2011) Int Immunopharmacol , vol.11 , pp. 1697-1705
    • Walker, M.R.1    Makropoulos, D.A.2    Achuthanandam, R.3    Vaan Arsdell, S.4    Bugelski, P.5
  • 22
    • 84861912234 scopus 로고    scopus 로고
    • Targeted therapy in hepatocellular carcinoma
    • Chua CW, Choo SP. Targeted therapy in hepatocellular carcinoma. Int J Hepatol 2011;2011:1-11.
    • (2011) Int J Hepatol , vol.2011 , pp. 1-11
    • Chua, C.W.1    Choo, S.P.2
  • 23
  • 24
    • 57749116172 scopus 로고    scopus 로고
    • Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215
    • Georges SA. Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215. Cancer Res 2008;68:10105-12.
    • (2008) Cancer Res , vol.68 , pp. 10105-10112
    • Georges, S.A.1
  • 25
    • 84883743256 scopus 로고    scopus 로고
    • TP53-independent function of miR-34a via HDAC1 and p21(CIP1/WAF1.)
    • Zhao J, Lammers P, Torrance CJ, Bader AG. TP53-independent function of miR-34a via HDAC1 and p21(CIP1/WAF1.). Mol Ther 2013;21:1678-86.
    • (2013) Mol Ther , vol.21 , pp. 1678-1686
    • Zhao, J.1    Lammers, P.2    Torrance, C.J.3    Bader, A.G.4
  • 26
    • 84864926277 scopus 로고    scopus 로고
    • New insights into p53 signaling and cancer cell response to DNA damage: Implications for cancer therapy
    • Mirzayans R, Andrais B, Scott A, Murray D. New insights into p53 signaling and cancer cell response to DNA damage: implications for cancer therapy. J Biomed Biotechnol 2012;2012:170325.
    • (2012) J Biomed Biotechnol , vol.2012 , pp. 170325
    • Mirzayans, R.1    Andrais, B.2    Scott, A.3    Murray, D.4
  • 27
    • 70450228519 scopus 로고    scopus 로고
    • Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells
    • Yuzugullu H, Benhaj K, Ozturk N, Senturk S, Celik E, Toylu A. Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells. Mol Cancer 2009;8:90.
    • (2009) Mol Cancer , vol.8 , pp. 90
    • Yuzugullu, H.1    Benhaj, K.2    Ozturk, N.3    Senturk, S.4    Celik, E.5    Toylu, A.6
  • 28
    • 55249106920 scopus 로고    scopus 로고
    • Wnt/beta-catenin pathway in hepatocellular carcinoma pathogenesis and liver physiology
    • Cavard C, Colnot S, Audard V, Benhamouche S, Finzi L, Torre C, et al. Wnt/beta-catenin pathway in hepatocellular carcinoma pathogenesis and liver physiology. Future Oncol 2008;4:647-60.
    • (2008) Future Oncol , vol.4 , pp. 647-660
    • Cavard, C.1    Colnot, S.2    Audard, V.3    Benhamouche, S.4    Finzi, L.5    Torre, C.6
  • 29
    • 77954119208 scopus 로고    scopus 로고
    • Molecular and functional genetics of hepatocellular carcinoma
    • Yam JW, Wong CM, Ng IO. Molecular and functional genetics of hepatocellular carcinoma. Front Biosci (Schol Ed) 2010;2:117-34.
    • (2010) Front Biosci(Schol Ed) , vol.2 , pp. 117-134
    • Yam, J.W.1    Wong, C.M.2    Ng, I.O.3
  • 30
    • 33751530490 scopus 로고    scopus 로고
    • Mining the Wnt pathway for cancer therapeutics
    • Barker N, Clevers H. Mining the Wnt pathway for cancer therapeutics. Nat Rev Drug Discov 2006;5:997-1014.
    • (2006) Nat Rev Drug Discov , vol.5 , pp. 997-1014
    • Barker, N.1    Clevers, H.2
  • 31
    • 67650230896 scopus 로고    scopus 로고
    • Wnt/beta-catenin signaling: Components, mechanisms, and diseases
    • MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 2009;17:9-26.
    • (2009) Dev Cell , vol.17 , pp. 9-26
    • MacDonald, B.T.1    Tamai, K.2    He, X.3
  • 32
    • 2542473135 scopus 로고    scopus 로고
    • Overexpression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: Its role in tumor progression and apoptosis
    • Huynh H, Nguyen TTT, Chow K-H P, Tan PH, Soo KC, Tran E. Overexpression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis. BMC Gastroenterol 2003;3:19.
    • (2003) BMC Gastroenterol , vol.3 , pp. 19
    • Huynh, H.1    Nguyen, T.T.T.2    Chow, K.-H.P.3    Tan, P.H.4    Soo, K.C.5    Tran, E.6
  • 33
    • 67749117934 scopus 로고    scopus 로고
    • Signal integration by JNK and p38 MAPK pathways in cancer development
    • Wagner EF, Nebreda AR. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Cancer Rev 2009;9:537-49.
    • (2009) Nat Cancer Rev , vol.9 , pp. 537-549
    • Wagner, E.F.1    Nebreda, A.R.2
  • 34
    • 64549120305 scopus 로고    scopus 로고
    • Role of Hedgehog signaling pathway in proliferation and invasiveness of hepatocellular carcinoma cells
    • Cheng WT, Xu K, Tian DY, Zhang ZG, Liu LJ, Chen Y. Role of Hedgehog signaling pathway in proliferation and invasiveness of hepatocellular carcinoma cells. Int J Oncol 2009;34:829-36.
    • (2009) Int J Oncol , vol.34 , pp. 829-836
    • Cheng, W.T.1    Xu, K.2    Tian, D.Y.3    Zhang, Z.G.4    Liu, L.J.5    Chen, Y.6
  • 35
    • 84860709668 scopus 로고    scopus 로고
    • Hedgehog signaling pathway mediates invasion and metastasis of hepatocellular carcinoma via ERK pathway
    • Lu J-t, Zhao W-d, He W, Wei W. Hedgehog signaling pathway mediates invasion and metastasis of hepatocellular carcinoma via ERK pathway. Acta Pharmacol Sin 2012;33:691-700.
    • (2012) Acta Pharmacol Sin , vol.33 , pp. 691-700
    • Lu, J.-T.1    Zhao, W.-D.2    He, W.3    Wei, W.4
  • 36
    • 84863264746 scopus 로고    scopus 로고
    • A polymeric nanoparticle encapsulated hedgehog pathway inhibitor HPI-1 (NanoHHI) inhibits systemic metastases in an orthotopic model of human hepatocellular carcinoma
    • Xu Y, Chenna V, Hu C, Sun HX, Khan M, Bai H, et al. A polymeric nanoparticle encapsulated hedgehog pathway inhibitor HPI-1 (NanoHHI) inhibits systemic metastases in an orthotopic model of human hepatocellular carcinoma. Clin Cancer Res 2012;18:1291-302.
    • (2012) Clin Cancer Res , vol.18 , pp. 1291-1302
    • Xu, Y.1    Chenna, V.2    Hu, C.3    Sun, H.X.4    Khan, M.5    Bai, H.6
  • 38
    • 80051728375 scopus 로고    scopus 로고
    • Future treatment option for hepatocellular carcinoma: A focus on brivanib
    • Kudo M. Future treatment option for hepatocellular carcinoma: a focus on brivanib. Dig Dis 2011;29:316-20.
    • (2011) Dig Dis , vol.29 , pp. 316-320
    • Kudo, M.1
  • 40
    • 67650305795 scopus 로고    scopus 로고
    • Targeting angiogenesis in hepatocellular carcinoma: Focus on VEGF and bevacizumab
    • Finn RS, Zhu AX. Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab. Expert Rev Anticancer Ther 2009; 9:503-9.
    • (2009) Expert Rev Anticancer Ther , vol.9 , pp. 503-509
    • Finn, R.S.1    Zhu, A.X.2
  • 41
    • 70350507211 scopus 로고    scopus 로고
    • Vascular endothelial growth factor in the management of hepatocellular carcinoma: A review of literature
    • Kaseb AO, Hanbali A, Cotant M, Hassan MM, Wollner I, Philip PA. Vascular endothelial growth factor in the management of hepatocellular carcinoma: a review of literature. Cancer 2009;115:4895-906.
    • (2009) Cancer , vol.115 , pp. 4895-4906
    • Kaseb, A.O.1    Hanbali, A.2    Cotant, M.3    Hassan, M.M.4    Wollner, I.5    Philip, P.A.6
  • 42
    • 0030951358 scopus 로고    scopus 로고
    • Expression of hepatocyte growth factor and its receptor c-met proto-oncog
    • Ueki T, Fujimoto J, Suzuki T, Yamimoto H, Okamoto E. Expression of hepatocyte growth factor and its receptor c-met proto-oncog. Hepatology 1997;25:862-6.
    • (1997) Hepatology , vol.25 , pp. 862-866
    • Ueki, T.1    Fujimoto, J.2    Suzuki, T.3    Yamimoto, H.4    Okamoto, E.5
  • 43
    • 79955952335 scopus 로고    scopus 로고
    • Medical treatment of unresectable hepatocellular carcinoma: Going beyond sorafenib
    • Porta C, Paglino C. Medical treatment of unresectable hepatocellular carcinoma: going beyond sorafenib. World J Hepatol 2010;2:103-13.
    • (2010) World J Hepatol , vol.2 , pp. 103-113
    • Porta, C.1    Paglino, C.2
  • 44
    • 0037442149 scopus 로고    scopus 로고
    • Current treatment for liver metastases from colorectal cancer
    • Liu LX, Zhang WH, Jiang HC. Current treatment for liver metastases from colorectal cancer. World J Gastroenterol 2003;9:193-200.
    • (2003) World J Gastroenterol , vol.9 , pp. 193-200
    • Liu, L.X.1    Zhang, W.H.2    Jiang, H.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.